abrdn reports 8.82% Codexis (CDXS) stake in Schedule 13G/A filing update
Rhea-AI Filing Summary
Aberdeen Group plc and abrdn Inc. filed an amended Schedule 13G reporting their beneficial ownership of 7,966,498 shares of Codexis, Inc. common stock, representing 8.82% of the class as of 12/31/2025. All of these shares are reported with shared voting and shared dispositive power, with no sole voting or dispositive authority.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Codexis. abrdn Inc. holds the position on behalf of underlying clients, with Aberdeen Group plc as the parent company and abrdn Holdings Limited as an intermediate holding company.
Positive
- None.
Negative
- None.
FAQ
What percentage of Codexis (CDXS) does abrdn report owning?
Aberdeen Group plc and abrdn Inc. report beneficial ownership of 8.82% of Codexis, Inc.'s common stock, based on 7,966,498 shares.
Who are the reporting persons in this Codexis Schedule 13G/A filing?
The reporting persons are Aberdeen Group plc and abrdn Inc., with Aberdeen Group plc as the parent company and abrdn Holdings Limited as the intermediate holding company for abrdn Inc.
Do Aberdeen Group plc and abrdn Inc. seek to influence control of Codexis?
No. They certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Codexis, Inc.
As of what date is the Codexis ownership information reported in this Schedule 13G/A?
The ownership information is reported as of 12/31/2025, which is the date of the event requiring the filing.